Issues related to the quality of cancer care; Health reform implementation related to the regulation and coverage of cancer care and treatments; Health disparities in cancer care; Cancer therapy development; Health information technology.
Issues pertaining to the federal governments regulation and coverage of cancer care and treatments (Covering Life-saving Investigations Needed in Cancer and Other Life-threatening Conditions through Timely use of Resources for Easy and Affordable Treatment from Medicaid for Enrollees in Need Today Act - H.R. 6836)
Duration: April 1, 2010
to
January 31, 2019
General Issues: Health Issues , Medicare/Medicaid , Budget/Appropriations
Spending: about $1,920,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2010: U.S. Senate, House of Representatives, Health & Human Services - Dept of (HHS), Food & Drug Administration (FDA), Office of Management & Budget (OMB), Vice President of the U.S., White House Office, Centers For Medicare and Medicaid Services (CMS), Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Health & Human Services - Dept of (HHS),
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
1st Quarter, 2019
Polsinelli PC terminated an engagement in which they represented American Society of Clinical Oncology on April 5, 2019.
Original Filing: 301022927.xml
Lobbying Issues
Issues related to the quality of cancer care; Health reform implementation related to the regulation and coverage of cancer care and treatments; Health disparities in cancer care; Cancer therapy development; Health information technology.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Food & Drug Administration (FDA) Office of Management & Budget (OMB) Vice President of the U.S. White House Office
Lobbying Issues
Issues pertaining to the federal governments regulation and coverage of cancer care and treatments (Covering Life-saving Investigations Needed in Cancer and Other Life-threatening Conditions through Timely use of Resources for Easy and Affordable Treatment from Medicaid for Enrollees in Need Today Act - H.R. 6836)
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS)
4th Quarter, 2018
In Q4, Polsinelli PC lobbied for American Society of Clinical Oncology , earning $60,000. The report was filed on Jan. 15, 2019.
Original Filing: 301004737.xml
Lobbying Issues
Issues related to the quality of cancer care; Health reform implementation issues pertaining to the regulation and coverage of cancer care and treatments; Issues pertaining to average sales price;Issues pertaining to health disparities in cancer care; Issues pertaining to the development of cancer therapies; Issues pertaining to health information technology
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Food & Drug Administration (FDA) Office of Management & Budget (OMB) Vice President of the U.S. White House Office
Lobbying Issues
Issues pertaining to the federal government's regulation and coverage of cancer care and treatments (Covering Life-saving Investigations Needed in Cancer and Other Life-threatening Conditions through Timely use of Resources for Easy and Affordable Treatment from Medicaid for Enrollees in Need Today Act - H.R. 6836);
Health reform implementation issues pertaining to the regulation and coverage of cancer care and treatments
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS)
3rd Quarter, 2018
In Q3, Polsinelli PC lobbied for American Society of Clinical Oncology , earning $60,000. The report was filed on Oct. 10, 2018.
Original Filing: 300984044.xml
Lobbying Issues
Issues related to the quality of cancer care; Health reform implementation issues pertaining to the regulation and coverage of cancer care and treatments; Issues pertaining to average sales price;Issues pertaining to health disparities in cancer care; Issues pertaining to the development of cancer therapies; Issues pertaining to health information technology
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Food & Drug Administration (FDA) Office of Management & Budget (OMB) Vice President of the U.S. White House Office
Lobbying Issues
Issues pertaining to the federal government's regulation and coverage of cancer care and treatments (Covering Life-saving Investigations Needed in Cancer and Other Life-threatening Conditions through Timely use of Resources for Easy and Affordable Treatment from Medicaid for Enrollees in Need Today Act - H.R. 6836);
Health reform implementation issues pertaining to the regulation and coverage of cancer care and treatments
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS)
2nd Quarter, 2018
In Q2, Polsinelli PC lobbied for American Society of Clinical Oncology , earning $60,000. The report was filed on July 13, 2018.
Original Filing: 300964649.xml
Lobbying Issues
Issues related to the quality of cancer care; Health reform implementation issues pertaining to the regulation and coverage of cancer care and treatments; Issues pertaining to average sales price;Issues pertaining to health disparities in cancer care; Issues pertaining to the development of cancer therapies; Issues pertaining to health information technology
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Food & Drug Administration (FDA) Office of Management & Budget (OMB) Vice President of the U.S. White House Office
Lobbying Issues
Issues pertaining to the federal government's regulation and coverage of cancer care and treatments; Health reform implementation issues pertaining to the regulation and coverage of cancer care and treatments
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS)
1st Quarter, 2018
In Q1, Polsinelli PC lobbied for American Society of Clinical Oncology , earning $60,000. The report was filed on April 17, 2018.
Original Filing: 300946517.xml
Lobbying Issues
Issues related to the quality of cancer care; Health reform implementation issues pertaining to the regulation and coverage of cancer care and treatments; Issues pertaining to average sales price;Issues pertaining to health disparities in cancer care; Issues pertaining to the development of cancer therapies; Issues pertaining to health information technology
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Food & Drug Administration (FDA) Office of Management & Budget (OMB) Vice President of the U.S. White House Office
Lobbying Issues
Issues pertaining to the federal government's regulation and coverage of cancer care and treatments; Health reform implementation issues pertaining to the regulation and coverage of cancer care and treatments
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS)
4th Quarter, 2017
In Q4, Polsinelli PC lobbied for American Society of Clinical Oncology , earning $40,000. The report was filed on Jan. 12, 2018.
Original Filing: 300923360.xml
Lobbying Issues
Issues related to the quality of cancer care; Health reform implementation issues pertaining to the regulation and coverage of cancer care and treatments; Issues pertaining to average sales price;Issues pertaining to health disparities in cancer care; Issues pertaining to the development of cancer therapies; Issues pertaining to health information technology
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Food & Drug Administration (FDA) Office of Management & Budget (OMB) Vice President of the U.S. White House Office
Lobbying Issues
Issues pertaining to the federal government's regulation and coverage of cancer care and treatments; Health reform implementation issues pertaining to the regulation and coverage of cancer care and treatments
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS)
3rd Quarter, 2017
In Q3, Polsinelli PC lobbied for American Society of Clinical Oncology , earning $40,000. The report was filed on Oct. 19, 2017.
Original Filing: 300909191.xml
Lobbying Issues
Issues related to the quality of cancer care; Health reform implementation issues pertaining to the regulation and coverage of cancer care and treatments; Issues pertaining to average sales price;Issues pertaining to health disparities in cancer care; Issues pertaining to the development of cancer therapies; Issues pertaining to health information technology
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Food & Drug Administration (FDA) Office of Management & Budget (OMB) Vice President of the U.S.
Lobbying Issues
Issues pertaining to the federal government's regulation and coverage of cancer care and treatments; Health reform implementation issues pertaining to the regulation and coverage of cancer care and treatments
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS)
2nd Quarter, 2017
In Q2, Polsinelli PC lobbied for American Society of Clinical Oncology , earning $40,000. The report was filed on July 18, 2017.
Original Filing: 300887354.xml
Lobbying Issues
Issues related to the quality of cancer care; Health reform implementation issues pertaining to the regulation and coverage of cancer care and treatments; Issues pertaining to average sales price;Issues pertaining to health disparities in cancer care; Issues pertaining to the development of cancer therapies; Issues pertaining to health information technology
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Food & Drug Administration (FDA)
Lobbying Issues
Issues pertaining to the federal government's regulation and coverage of cancer care and treatments; Health reform implementation issues pertaining to the regulation and coverage of cancer care and treatments
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS)
1st Quarter, 2017
In Q1, Polsinelli PC lobbied for American Society of Clinical Oncology , earning $40,000. The report was filed on April 19, 2017.
Original Filing: 300869066.xml
Lobbying Issues
Issues related to the quality of cancer care; Health reform implementation issues pertaining to the regulation and coverage of cancer care and treatments; Issues pertaining to average sales price;Issues pertaining to health disparities in cancer care; Issues pertaining to the development of cancer therapies; Issues pertaining to health information technology
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Food & Drug Administration (FDA)
Lobbying Issues
Issues pertaining to the federal government's regulation and coverage of cancer care and treatments; Health reform implementation issues pertaining to the regulation and coverage of cancer care and treatments
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS)
4th Quarter, 2016
In Q4, Polsinelli PC lobbied for American Society of Clinical Oncology , earning $40,000. The report was filed on Jan. 10, 2017.
Original Filing: 300844774.xml
Lobbying Issues
Issues related to the quality of cancer care; Health reform implementation issues pertaining to the regulation and coverage of cancer care and treatments; Issues pertaining to average sales price;Issues pertaining to health disparities in cancer care; Issues pertaining to the development of cancer therapies; Issues pertaining to health information technology [S.2141 - TRUST IT Act]; S.524 - Comprehensive Addiction and Recovery Act of 2016
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Food & Drug Administration (FDA)
Lobbying Issues
Issues pertaining to the federal government's regulation and coverage of cancer care and treatments [H.R.5122 - Medicare Part B Drug Payment Demonstration]; Health reform implementation issues pertaining to the regulation and coverage of cancer care and treatments
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS)
3rd Quarter, 2016
In Q3, Polsinelli PC lobbied for American Society of Clinical Oncology , earning $40,000. The report was filed on Oct. 11, 2016.
Original Filing: 300826413.xml
Lobbying Issues
Issues related to the quality of cancer care; Health reform implementation issues pertaining to the regulation and coverage of cancer care and treatments; Issues pertaining to average sales price;Issues pertaining to health disparities in cancer care; Issues pertaining to the development of cancer therapies; Issues pertaining to health information technology [S.2141 - TRUST IT Act]; S.524 - Comprehensive Addiction and Recovery Act of 2016
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Food & Drug Administration (FDA)
Lobbying Issues
Issues pertaining to the federal government's regulation and coverage of cancer care and treatments [H.R.5122 - Medicare Part B Drug Payment Demonstration]; Health reform implementation issues pertaining to the regulation and coverage of cancer care and treatments
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS)
2nd Quarter, 2016
In Q2, Polsinelli PC lobbied for American Society of Clinical Oncology , earning $40,000. The report was filed on July 15, 2016.
Original Filing: 300810039.xml
Lobbying Issues
Issues related to the quality of cancer care; Health reform implementation issues pertaining to the regulation and coverage of cancer care and treatments; Issues pertaining to average sales price;Issues pertaining to health disparities in cancer care; Issues pertaining to the development of cancer therapies; Issues pertaining to health information technology [S.2141 - TRUST IT Act]; S.524 - Comprehensive Addiction and Recovery Act of 2016
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Food & Drug Administration (FDA)
Lobbying Issues
Issues pertaining to the federal government's regulation and coverage of cancer care and treatments; Health reform implementation issues pertaining to the regulation and coverage of cancer care and treatments
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS)
1st Quarter, 2016
In Q1, Polsinelli PC lobbied for American Society of Clinical Oncology , earning $40,000. The report was filed on April 19, 2016.
Original Filing: 300794442.xml
Lobbying Issues
Issues related to the quality of cancer care; Health reform implementation issues pertaining to the regulation and coverage of cancer care and treatments; Issues pertaining to average sales price;Issues pertaining to health disparities in cancer care; Issues pertaining to the development of cancer therapies; Issues pertaining to health information technology [S.2141 - TRUST IT Act]
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Food & Drug Administration (FDA)
Lobbying Issues
Issues pertaining to the federal government's regulation and coverage of cancer care and treatments; Health reform implementation issues pertaining to the regulation and coverage of cancer care and treatments
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS)
4th Quarter, 2015
In Q4, Polsinelli PC lobbied for American Society of Clinical Oncology , earning $40,000. The report was filed on Jan. 8, 2016.
Original Filing: 300769929.xml
Lobbying Issues
Issues related to the quality of cancer care; Health reform implementation issues pertaining to the regulation and coverage of cancer care and treatments; Issues pertaining to average sales price;Issues pertaining to health disparities in cancer care; Issues pertaining to the development of cancer therapies [21st Century Cures (H.R. 6)]; Issues pertaining to health information technology
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Food & Drug Administration (FDA)
Lobbying Issues
Issues pertaining to the federal government's regulation and coverage of cancer care and treatments; Health reform implementation issues pertaining to the regulation and coverage of cancer care and treatments
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS)
3rd Quarter, 2015
In Q3, Polsinelli PC lobbied for American Society of Clinical Oncology , earning $40,000. The report was filed on Oct. 19, 2015.
Original Filing: 300756595.xml
Lobbying Issues
Issues related to the quality of cancer care; Health reform implementation issues pertaining to the regulation and coverage of cancer care and treatments; Issues pertaining to average sales price;Issues pertaining to health disparities in cancer care; Issues pertaining to the development of cancer therapies [21st Century Cures (H.R. 6)]; Issues pertaining to health information technology
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Food & Drug Administration (FDA)
Lobbying Issues
Issues pertaining to the federal government's regulation and coverage of cancer care and treatments; Health reform implementation issues pertaining to the regulation and coverage of cancer care and treatments
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS)
2nd Quarter, 2015
In Q2, Polsinelli PC lobbied for American Society of Clinical Oncology , earning $60,000. The report was filed on July 9, 2015.
Original Filing: 300732666.xml
Lobbying Issues
Issues related to the quality of cancer care; Health reform implementation issues pertaining to the regulation and coverage of cancer care and treatments; Issues pertaining to average sales price;Issues pertaining to health disparities in cancer care; Issues pertaining to the development of cancer therapies [21st Century Cures (H.R. 6)]
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Food & Drug Administration (FDA)
Lobbying Issues
Issues pertaining to the federal government's regulation and coverage of cancer care and treatments; Health reform implementation issues pertaining to the regulation and coverage of cancer care and treatments; Reform of Medicare physician fee schedule and formula [Medicare Access and CHIP Reauthorization Act of 2015 (H.R. 2)]
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS)
1st Quarter, 2015
In Q1, Polsinelli PC lobbied for American Society of Clinical Oncology , earning $60,000. The report was filed on April 20, 2015.
Original Filing: 300726129.xml
Lobbying Issues
Issues related to the quality of cancer care; Health reform implementation issues pertaining to the regulation and coverage of cancer care and treatments; Issues pertaining to average sales price;Issues pertaining to health disparities in cancer care
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Food & Drug Administration (FDA)
Lobbying Issues
Issues pertaining to the federal government's regulation and coverage of cancer care and treatments; Health reform implementation issues pertaining to the regulation and coverage of cancer care and treatments; Reform of Medicare physician fee schedule and formula [Medicare Access and CHIP Reauthorization Act of 2015 (HR 2)]
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS)
4th Quarter, 2014
In Q4, Polsinelli PC (FKA Polsinelli Shughart PC) lobbied for American Society of Clinical Oncology , earning $60,000. The report was filed on Jan. 20, 2015.
Original Filing: 300702198.xml
Lobbying Issues
Issues related to the quality of cancer care; Health reform implementation issues pertaining to the regulation and coverage of cancer care and treatments; Issues pertaining to average sales price; Kids First Research Act, H.R. 2019 - all provisions
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS) Food & Drug Administration (FDA) Health & Human Services - Dept of (HHS)
Lobbying Issues
Issues pertaining to the federal government's regulation and coverage of cancer care and treatments; Health reform implementation issues pertaining to the regulation and coverage of cancer care and treatments; Reform of Medicare physician fee schedule and formula [Medicare Patient Access and Quality Improvement Act (H.R. 2810); SGR Repeal and Medicare Beneficiary Access Act (S. 1871); con't.]SGR Repeal and Medicare Provider Payment Modernization Act (H.R. 4015); Medicare SGR Repeal and Beneficiary Access Improvement Act (S. 2110)]
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS),
3rd Quarter, 2014
In Q3, Polsinelli PC (FKA Polsinelli Shughart PC) lobbied for American Society of Clinical Oncology , earning $60,000. The report was filed on Oct. 20, 2014.
Original Filing: 300684758.xml
Lobbying Issues
Issues related to the quality of cancer care; Health reform implementation issues pertaining to the regulation and coverage of cancer care and treatments; Issues pertaining to average sales price; Kids First Research Act, H.R. 2019 - all provisions
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS) Food & Drug Administration (FDA) Health & Human Services - Dept of (HHS)
Lobbying Issues
Issues pertaining to the federal government's regulation and coverage of cancer care and treatments; Health reform implementation issues pertaining to the regulation and coverage of cancer care and treatments; Reform of Medicare physician fee schedule and formula [Medicare Patient Access and Quality Improvement Act (H.R. 2810); SGR Repeal and Medicare Beneficiary Access Act (S. 1871); con't.]SGR Repeal and Medicare Provider Payment Modernization Act (H.R. 4015); Medicare SGR Repeal and Beneficiary Access Improvement Act (S. 2110)]
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS),
2nd Quarter, 2014
In Q2, Polsinelli PC (FKA Polsinelli Shughart PC) lobbied for American Society of Clinical Oncology , earning $60,000. The report was filed on July 18, 2014.
Original Filing: 300661396.xml
Lobbying Issues
Issues related to the quality of cancer care; Health reform implementation issues pertaining to the regulation and coverage of cancer care and treatments; Issues pertaining to average sales price; Kids First Research Act, H.R. 2019 - all provisions
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS) Food & Drug Administration (FDA) Health & Human Services - Dept of (HHS)
Lobbying Issues
Issues pertaining to the federal government's regulation and coverage of cancer care and treatments; Health reform implementation issues pertaining to the regulation and coverage of cancer care and treatments; Reform of Medicare physician fee schedule and formula [Medicare Patient Access and Quality Improvement Act (H.R. 2810); SGR Repeal and Medicare Beneficiary Access Act (S. 1871); con't.]SGR Repeal and Medicare Provider Payment Modernization Act (H.R. 4015); Medicare SGR Repeal and Beneficiary Access Improvement Act (S. 2110)]
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS),
1st Quarter, 2014
In Q1, Polsinelli PC (FKA Polsinelli Shughart PC) lobbied for American Society of Clinical Oncology , earning $60,000. The report was filed on April 17, 2014.
Original Filing: 300640211.xml
Lobbying Issues
Issues related to the quality of cancer care; Health reform implementation issues pertaining to the regulation and coverage of cancer care and treatments; Issues pertaining to average sales price; Kids First Research Act, H.R. 2019 - all provisions
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS) Food & Drug Administration (FDA) Health & Human Services - Dept of (HHS)
Lobbying Issues
Issues pertaining to the federal government's regulation and coverage of cancer care and treatments; Health reform implementation issues pertaining to the regulation and coverage of cancer care and treatments; Reform of Medicare physician fee schedule and formula [Medicare Patient Access and Quality Improvement Act (H.R. 2810); SGR Repeal and Medicare Beneficiary Access Act (S. 1871); con't.]SGR Repeal and Medicare Provider Payment Modernization Act (H.R. 4015); Medicare SGR Repeal and Beneficiary Access Improvement Act (S. 2110)]
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS),
4th Quarter, 2013
In Q4, Polsinelli PC (FKA Polsinelli Shughart PC) lobbied for American Society of Clinical Oncology , earning $60,000. The report was filed on Jan. 17, 2014.
Original Filing: 300619024.xml
Lobbying Issues
Issues related to the quality of cancer care; Health reform implementation issues pertaining to the regulation and coverage of cancer care and treatments; Issues pertaining to average sales price; Kids First Research Act, H.R. 2019 - all provisions
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS) Food & Drug Administration (FDA) Health & Human Services - Dept of (HHS)
Lobbying Issues
Issues pertaining to the federal government's regulation and coverage of cancer care and treatments; Health reform implementation issues pertaining to the regulation and coverage of cancer care and treatments; Reform of Medicare physician fee schedule and formula [Medicare Patient Access and Quality Improvement Act (H.R. 2810); SGR Repeal and Medicare Beneficiary Access Act (S. 1871)]
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS),
3rd Quarter, 2013
In Q3, Polsinelli PC (FKA Polsinelli Shughart PC) lobbied for American Society of Clinical Oncology , earning $60,000. The report was filed on Oct. 21, 2013.
Original Filing: 300606780.xml
Lobbying Issues
Issues related to the quality of cancer care; Health reform implementation issues pertaining to the regulation and coverage of cancer care and treatments; Issues pertaining to average sales price; Kids First Research Act, H.R. 2019 - all provisions
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS) Food & Drug Administration (FDA) Health & Human Services - Dept of (HHS)
Lobbying Issues
Issues pertaining to the federal government's regulation and coverage of cancer care and treatments; Health reform implementation issues pertaining to the regulation and coverage of cancer care and treatments; Reform of Medicare physician fee schedule and formula
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS) Food & Drug Administration (FDA) Health & Human Services - Dept of (HHS)
2nd Quarter, 2013
In Q2, Polsinelli PC (FKA Polsinelli Shughart PC) lobbied for American Society of Clinical Oncology , earning $60,000. The report was filed on July 19, 2013.
Original Filing: 300579674.xml
Lobbying Issues
Issues related to the quality of cancer care; Health reform implementation issues pertaining to the regulation and coverage of cancer care and treatments; Issues pertaining to average sales price; Kids First Research Act, H.R. 2019 - all provisions
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS) Food & Drug Administration (FDA) Health & Human Services - Dept of (HHS)
Lobbying Issues
Issues pertaining to the federal government's regulation and coverage of cancer care and treatments; Health reform implementation issues pertaining to the regulation and coverage of cancer care and treatments; Reform of Medicare physician fee schedule and formula
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS) Food & Drug Administration (FDA) Health & Human Services - Dept of (HHS)
1st Quarter, 2013
In Q1, Polsinelli Shughart PC lobbied for American Society of Clinical Oncology , earning $60,000. The report was filed on April 22, 2013.
Original Filing: 300562894.xml
Lobbying Issues
Issues related to the quality of cancer care; Health reform implementation issues pertaining to the regulation and coverage of cancer care and treatments; Issues pertaining to average sales price
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS) Food & Drug Administration (FDA) Health & Human Services - Dept of (HHS)
Lobbying Issues
Issues pertaining to the federal government's regulation and coverage of cancer care and treatments; Health reform implementation issues pertaining to the regulation and coverage of cancer care and treatments; Reform of Medicare physician fee schedule and formula
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS) Food & Drug Administration (FDA) Health & Human Services - Dept of (HHS)
4th Quarter, 2012
In Q4, Polsinelli Shughart PC lobbied for American Society of Clinical Oncology , earning $60,000. The report was filed on Jan. 22, 2013.
Original Filing: 300541819.xml
Lobbying Issues
Issues related to the quality of cancer care [Preserving Access to Life-Saving Medications Act (S. 296, H.R. 2245) -- all provisions]; Health reform implementation issues pertaining to the regulation and coverage of cancer care and treatments; Issues pertaining to average sales price
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS) Food & Drug Administration (FDA) Health & Human Services - Dept of (HHS)
Lobbying Issues
Issues pertaining to the federal government's regulation and coverage of cancer care and treatments; Health reform implementation issues pertaining to the regulation and coverage of cancer care and treatments; Reform of Medicare physician fee schedule and formula
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS) Food & Drug Administration (FDA) Health & Human Services - Dept of (HHS)
3rd Quarter, 2012
In Q3, Polsinelli Shughart PC lobbied for American Society of Clinical Oncology , earning $60,000. The report was filed on Oct. 22, 2012.
Original Filing: 300520102.xml
Lobbying Issues
Issues related to the quality of cancer care [Preserving Access to Life-Saving Medications Act (S. 296, H.R. 2245) -- all provisions]; Health reform implementation issues pertaining to the regulation and coverage of cancer care and treatments; Issues pertaining to average sales price
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS) Food & Drug Administration (FDA) Health & Human Services - Dept of (HHS)
Lobbying Issues
Issues pertaining to the federal government's regulation and coverage of cancer care and treatments; Health reform implementation issues pertaining to the regulation and coverage of cancer care and treatments; Reform of Medicare physician fee schedule and formula
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS) Food & Drug Administration (FDA) Health & Human Services - Dept of (HHS)
2nd Quarter, 2012
In Q2, Polsinelli Shughart PC lobbied for American Society of Clinical Oncology , earning $60,000. The report was filed on July 20, 2012.
Original Filing: 300493968.xml
Lobbying Issues
Issues related to the quality of cancer care [Preserving Access to Life-Saving Medications Act (S. 296, H.R. 2245) -- all provisions]; Health reform implementation issues pertaining to the regulation and coverage of cancer care and treatments; Issues pertaining to average sales price
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS) Food & Drug Administration (FDA) Health & Human Services - Dept of (HHS)
Lobbying Issues
Issues pertaining to the federal government's regulation and coverage of cancer care and treatments; Health reform implementation issues pertaining to the regulation and coverage of cancer care and treatments; Reform of Medicare physician fee schedule and formula
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS) Food & Drug Administration (FDA) Health & Human Services - Dept of (HHS)
1st Quarter, 2012
In Q1, Polsinelli Shughart PC lobbied for American Society of Clinical Oncology , earning $60,000. The report was filed on April 20, 2012.
Original Filing: 300471544.xml
Lobbying Issues
Issues related to the quality of cancer care [Preserving Access to Life-Saving Medications Act (S. 296, H.R. 2245) -- all provisions]; Health reform implementation issues pertaining to the regulation and coverage of cancer care and treatments; Issues pertaining to average sales price
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS) Food & Drug Administration (FDA) Health & Human Services - Dept of (HHS)
Lobbying Issues
Issues pertaining to the federal government's regulation and coverage of cancer care and treatments; Health reform implementation issues pertaining to the regulation and coverage of cancer care and treatments; Reform of Medicare physician fee schedule and formula
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS) Food & Drug Administration (FDA) Health & Human Services - Dept of (HHS)
4th Quarter, 2011
In Q4, Polsinelli Shughart PC lobbied for American Society of Clinical Oncology , earning $60,000. The report was filed on Jan. 19, 2012.
Original Filing: 300442979.xml
Lobbying Issues
Issues related to the quality of cancer care [Preserving Access to Life-Saving Medications Act (S. 296, H.R. 2245) -- all provisions]; Health reform implementation issues pertaining to the regulation and coverage of cancer care and treatments; Issues pertaining to average sales price
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS) Food & Drug Administration (FDA) Health & Human Services - Dept of (HHS)
Lobbying Issues
Issues pertaining to the federal government's regulation and coverage of cancer care and treatments; Health reform implementation issues pertaining to the regulation and coverage of cancer care and treatments; Reform of Medicare physician fee schedule and formula
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS) Food & Drug Administration (FDA) Health & Human Services - Dept of (HHS)
3rd Quarter, 2011
In Q3, Polsinelli Shughart PC lobbied for American Society of Clinical Oncology , earning $60,000. The report was filed on Oct. 19, 2011.
Original Filing: 300418865.xml
Lobbying Issues
Issues related to the quality of cancer care [Preserving Access to Life-Saving Medications Act (S. 296) -- all provisions]; Health reform implementation issues pertaining to the regulation and coverage of cancer care and treatments; Issues pertaining to average sales price
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS) Food & Drug Administration (FDA) Health & Human Services - Dept of (HHS)
Lobbying Issues
Issues pertaining to the federal government's regulation and coverage of cancer care and treatments; Health reform implementation issues pertaining to the regulation and coverage of cancer care and treatments; Reform of Medicare physician fee schedule and formula
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS) Food & Drug Administration (FDA) Health & Human Services - Dept of (HHS)
2nd Quarter, 2011
In Q2, Polsinelli Shughart PC lobbied for American Society of Clinical Oncology , earning $60,000. The report was filed on July 15, 2011.
Original Filing: 300391435.xml
Lobbying Issues
Issues related to the quality of cancer care [Preserving Access to Life-Saving Medications Act (S. 296) -- all provisions]; Health reform implementation issues pertaining to the regulation and coverage of cancer care and treatments
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS) Food & Drug Administration (FDA) Health & Human Services - Dept of (HHS)
Lobbying Issues
Issues pertaining to the federal government's regulation and coverage of cancer care and treatments; Health reform implementation issues pertaining to the regulation and coverage of cancer care and treatments; Reform of Medicare physician fee schedule and formula
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS) Food & Drug Administration (FDA) Health & Human Services - Dept of (HHS)
1st Quarter, 2011
In Q1, Polsinelli Shughart PC lobbied for American Society of Clinical Oncology , earning $60,000. The report was filed on April 19, 2011.
Original Filing: 300371153.xml
Lobbying Issues
Issues related to the quality of cancer care [Preserving Access to Life-Saving Medications Act (S. 296) -- all provisions]; Health reform implementation issues pertaining to the regulation and coverage of cancer care and treatments
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS) Food & Drug Administration (FDA) Health & Human Services - Dept of (HHS)
Lobbying Issues
Issues pertaining to the federal government's regulation and coverage of cancer care and treatments; Health reform implementation issues pertaining to the regulation and coverage of cancer care and treatments; Reform of Medicare physician fee schedule and formula
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS) Food & Drug Administration (FDA) Health & Human Services - Dept of (HHS)
4th Quarter, 2010
In Q4, Polsinelli Shughart PC lobbied for American Society of Clinical Oncology , earning $60,000. The report was filed on Jan. 19, 2011.
Original Filing: 300345476.xml
Lobbying Issues
Issues related to the quality of cancer care [Mammogram and MRI Availability Act (H.R. 995) - all provisions; Breast Cancer Patient Protection Act (H.R. 1691) - all provisions; Breast Cancer Education and Awareness Requires Learning Young Act (H.R. 1740) - all provisions]; Health reform implementation issues pertaining to the regulation and coverage of cancer care and treatments
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS) Food & Drug Administration (FDA) Health & Human Services - Dept of (HHS)
Lobbying Issues
Issues pertaining to the federal government's regulation and coverage of cancer care and treatments [Comprehensive Cancer Care Improvement Act (H.R. 1844) all provisions; Cancer Trial Coverage (S. 717) -- all provisions; Legislation eliminating the prompt-pay discount from the Medicare average sales price calculation (H.R. 1392; S. 1221); Medicare Cancer Patients Database and Coverage Act (H.R. 3095) -- all provisions; Eliminating Disparities in Breast Cancer Treatment Act (H.R. 2279) - all provisions]Health reform implementation issues pertaining to the regulation and coverage of cancer care and treatments; Reform of Medicare physician fee schedule and formula [Medicare and Medicaid Extenders Act (H.R. 4994)]
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS) Food & Drug Administration (FDA) Health & Human Services - Dept of (HHS)
3rd Quarter, 2010
In Q3, Polsinelli Shughart PC lobbied for American Society of Clinical Oncology , earning $60,000. The report was filed on Oct. 15, 2010.
Original Filing: 300313974.xml
Lobbying Issues
Issues related to the quality of cancer care [Mammogram and MRI Availability Act (H.R. 995) - all provisions; Breast Cancer Patient Protection Act (H.R. 1691) - all provisions; Breast Cancer Education and Awareness Requires Learning Young Act (H.R. 1740) - all provisions]; Health reform implementation issues pertaining to the regulation and coverage of cancer care and treatments
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS) Food & Drug Administration (FDA) Health & Human Services - Dept of (HHS)
Lobbying Issues
Issues pertaining to the federal government's regulation and coverage of cancer care and treatments [Comprehensive Cancer Care Improvement Act (H.R. 1844) all provisions; Cancer Trial Coverage (S. 717) -- all provisions; Legislation eliminating the prompt-pay discount from the Medicare average sales price calculation (H.R. 1392; S. 1221); Medicare Cancer Patients Database and Coverage Act (H.R. 3095) -- all provisions; Eliminating Disparities in Breast Cancer Treatment Act (H.R. 2279) - all provisions]Health reform implementation issues pertaining to the regulation and coverage of cancer care and treatments
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS) Food & Drug Administration (FDA) Health & Human Services - Dept of (HHS)
2nd Quarter, 2010
In Q2, Polsinelli Shughart PC lobbied for American Society of Clinical Oncology , earning $60,000. The report was filed on July 19, 2010.
Original Filing: 300291181.xml
Lobbying Issues
Issues related to the quality of cancer care [Mammogram and MRI Availability Act (H.R. 995) - all provisions; Breast Cancer Patient Protection Act (H.R. 1691) - all provisions; Breast Cancer Education and Awareness Requires Learning Young Act (H.R. 1740) - all provisions]; Health reform implementation issues pertaining to the regulation and coverage of cancer care and treatments
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS) Food & Drug Administration (FDA) Health & Human Services - Dept of (HHS)
Lobbying Issues
Issues pertaining to the federal government's regulation and coverage of cancer care and treatments [Comprehensive Cancer Care Improvement Act (H.R. 1844) all provisions; Cancer Trial Coverage (S. 717) -- all provisions; Legislation eliminating the prompt-pay discount from the Medicare average sales price calculation (H.R. 1392; S. 1221); Medicare Cancer Patients Database and Coverage Act (H.R. 3095) -- all provisions; Eliminating Disparities in Breast Cancer Treatment Act (H.R. 2279) - all provisions]Health reform implementation issues pertaining to the regulation and coverage of cancer care and treatments
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS) Food & Drug Administration (FDA) Health & Human Services - Dept of (HHS)
2nd Quarter, 2010
Polsinelli Shughart PC filed a lobbying registration on May 12, 2010 to represent American Society of Clinical Oncology, effective April 1, 2010.
Original Filing: 300278965.xml
Issue(s) they said they’d lobby about: Issues pertaining to the federal government's regulation and coverage of cancer care and treatments
Issues related to the quality of cancer care
Increase funding for National Institutes of Health programs as they pertain to cancer research .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate